A.M. Palache

Antibody landscapes after influenza virus infection or vaccination

Judith M. Fonville, Samuel Wilks, Sarah L. James et al. · Science · 2014 · 494 citations · Full text

Vaccination, Cross-protection, Vaccine Development +13

Haemagglutination-inhibiting antibody to influenza virus.

J.C. de Jong, A.M. Palache, W.E.P. Beyer et al. · PubMed · 2003 · 320 citations

Vaccination, Vaccine Safety, Median Hi Titre +12

Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly

J.C. de Jong, W.E.P. Beyer, A.M. Palache et al. · Journal of Medical Virology · 2000 · 230 citations · Full text

Vaccination, World Health Organization, Virus Variant +14

Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries

G VANESSEN, A.M. Palache, Eduardo Forleo et al. · Vaccine · 2003 · 193 citations

Vaccination, Vaccine Safety, Vaccinology +11

Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?

W.E.P. Beyer, A.M. Palache, Guido Lüchters et al. · Virus Research · 2004 · 173 citations

Vaccination, Seroconversion Rate, Infectious Disease Modelling +11